Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

Nature Reviews Nephrology is a prestigious academic journal published by NATURE PORTFOLIO, focusing on the rapidly evolving field of nephrology. As a leader in its category, it holds an impressive Q1 ranking in the 2023 category for Nephrology and ranks #1 out of 81 in the Scopus metrics, reflecting its high impact and relevance within the scientific community, with a staggering 99th percentile ranking. Established in 2009, this journal provides in-depth reviews, critical analysis, and cutting-edge research updates, making it an essential resource for researchers, professionals, and students alike. With an accessible Open Access policy, it enhances the dissemination of knowledge, ensuring that vital research in renal health and disease reaches a wide audience. Situated in the United Kingdom, Nature Reviews Nephrology remains committed to advancing understanding and treatment in nephrology, emphasizing the importance of this area of study in improving patient outcomes globally.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

NEPHRON is a premier peer-reviewed academic journal dedicated to advancing the field of nephrology and renal medicine. Published by KARGER, renowned for its commitment to quality research, NEPHRON serves as a vital resource for researchers, clinicians, and students interested in the latest findings and developments in kidney health. With an ISSN of 1660-8151 and an E-ISSN of 2235-3186, the journal ensures wide accessibility and dissemination of knowledge in the renal domain. Although specific impact metrics such as the HIndex are presently unavailable, NEPHRON's emphasis on Open Access publishing greatly enhances its visibility and accessibility, allowing groundbreaking research to reach a global audience. Through a comprehensive scope that encompasses clinical studies, basic research, and translational science, NEPHRON contributes significantly to the understanding and treatment of kidney diseases. Join the vibrant community of professionals and scholars who are shaping the future of nephrology by engaging with the wealth of knowledge presented in NEPHRON.

Nephrologie, published by Springer Heidelberg, is a vital addition to the field of nephrology, providing a dedicated platform for the dissemination of cutting-edge research and clinical practices in kidney health. With its ISSN 2731-7463 and E-ISSN 2731-7471, this journal facilitates open access to a range of articles aimed at enhancing understanding and treatment of renal disorders. Located in Germany, Nephrologie is recognized for its commitment to advancing nephrological knowledge despite being currently categorized in the Q4 quartile and holding a Scopus rank of #80/81 within its field, indicating its emerging potential in the academic landscape. Operating from Tiergartenstraße 17, D-69121 Heidelberg, Germany, the journal encompasses a diverse scope that includes original research, review articles, and clinical studies, fostering a collaborative environment among researchers, healthcare professionals, and students. As it converges between 2022 and 2024, Nephrologie positions itself as a crucial resource for those committed to improving renal patient care and outcomes.

The American Journal of Nephrology, published by KARGER, stands as a prestigious platform for the dissemination of high-quality research in the field of nephrology, boasting an impressive Q1 ranking in its category as of 2023. With its ISSN 0250-8095 and E-ISSN 1421-9670, the journal has been committed to advancing knowledge in kidney diseases since its inception in 1981. It serves as an essential resource for researchers, clinicians, and students alike, featuring original articles, reviews, and case reports that contribute to the understanding and treatment of renal conditions. Despite not being an open-access journal, the American Journal of Nephrology ensures a rigorous peer-review process to maintain its high academic standards, making it a vital source of information for the nephrology community worldwide. By providing insights into emerging trends and breakthroughs in kidney health, the journal continues to play a crucial role in shaping the future of nephrology research.

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

SEMINARS IN NEPHROLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier journal in the field of nephrology, with a notable impact factor in its category. With its dedicated scope spanning significant developments from 1981 to 2024, this journal provides an essential platform for researchers, clinicians, and students to explore critical advances in renal medicine. Noteworthy for its classification in the Q1 quartile of nephrology journals, SEMINARS IN NEPHROLOGY ranks #18 out of 81 in Scopus, placing it in the 78th percentile of its field, which underscores its influence and contribution to contemporary research. While it currently does not offer open access, the journal remains a vital resource for anyone seeking to deepen their understanding of nephrological advancements and complexities. With an established address located at 1600 John F. Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, it continues to draw a global readership committed to the pursuit of knowledge in kidney health and disease.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.